BUUU 15min chart shows MACD Death Cross, KDJ Death Cross, and Bearish Marubozu.

Based on the 15-minute chart of BUUU, the MACD Death Cross and KDJ Death Cross indicators were triggered on September 11, 2025 at 15:30, accompanied by a bearish Marubozu candlestick pattern. This suggests that the stock price is likely to continue declining, with a shift in momentum towards the downside, potentially leading to further decreases. Sellers appear to be in control of the market, and the bearish momentum is expected to persist.

Moolec Science (NASDAQ: MLEC), a biotechnology company specializing in molecular farming, has secured significant regulatory approvals and expanded its market reach. On September 11, 2025, at 15:30, the company announced three key developments.

First, Moolec received regulatory approval from SENASA in Argentina for its safflower GLASO technology. This approval enables the expansion of its GLA-enriched safflower crop production in Argentina. The company has also doubled its U.S. safflower acreage compared to last year, strengthening its supply capabilities for the pet food and human nutrition markets Moolec Science Stock Price, News & Analysis^[1].

Second, Moolec appointed Valeria Falottico as CFO, bringing over 20 years of financial expertise to the company. This strategic appointment underscores Moolec's commitment to financial stability and growth.

Additionally, Moolec completed the integration of Mycofood™, its fungal-based protein platform. The company is currently developing products for evaluation by food industry partners in North America and Europe.

These developments come amidst a challenging market environment. The MACD Death Cross and KDJ Death Cross indicators were triggered on September 11, 2025, at 15:30, accompanied by a bearish Marubozu candlestick pattern. This suggests a continued decline in the stock price, with sellers in control of the market. However, these regulatory approvals and market expansions indicate Moolec's resilience and strategic focus.

Moolec's recent regulatory approvals and market expansions highlight its commitment to sustainable biotechnology and its ability to navigate market challenges. As the company continues to grow and innovate, investors should closely monitor its progress and the broader market trends.

Moolec Science Stock Price, News & Analysis^[1]: Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment (Rhea-AI, 09/11/2025)